- Puma Biotechnology Reports First Quarter Financial Results
- Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
- Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results
- Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference
- Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results
- Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer
More ▼
Key statistics
On Friday, Puma Biotechnology Inc (0PB:BER) closed at 4.53, 118.41% above the 52 week low of 2.08 set on Oct 25, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.43 |
---|---|
High | 4.75 |
Low | 4.43 |
Bid | 4.37 |
Offer | 4.69 |
Previous close | 4.59 |
Average volume | 1.08k |
---|---|
Shares outstanding | 48.21m |
Free float | 40.78m |
P/E (TTM) | 10.99 |
Market cap | 239.11m USD |
EPS (TTM) | 0.4515 USD |
Data delayed at least 15 minutes, as of May 03 2024 19:21 BST.
More ▼